PP 130Alternative Names: PP-130
Latest Information Update: 19 Dec 2013
At a glance
- Originator Peritech Pharma
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase Unknown Fissure in ano
Most Recent Events
- 17 Dec 2013 Investigation in Fissure in ano in Israel (unspecified route)